Immuneering IMRX Cash Flow Statement (2020-2026)

NASDAQ IMRX
$3.72 +0.07 (+2.05%)
As of: Nov 10, 2026 · 12:11 PM EST
Reported Financials

Immuneering Quarterly Cash Flow Statement

Periods 26 quarters
Latest Sep 2026

Immuneering reported cash from operations of -$16.79M and free cash flow of -$16.80M for the quarter ended Sep 2026, down 40.1% year over year. This cash flow statement covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-10.78M-12.90M-11.53M-12.84M-13.25M-13.60M-12.19M-12.60M-15.08M-14.31M-14.08M-14.60M-18.05M-15.05M-14.43M-14.96M-11.58M-13.46M-17.27M-24.19M
Depreciation and DepletionDep. & Depletion
0.01M0.05M0.05M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.09M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.05M0.05M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.09M0.09M0.08M0.08M0.08M0.08M0.08M0.09M
Share-based CompensationStock Comp.
0.63M0.90M1.05M1.07M1.05M1.27M1.33M1.48M1.64M1.47M1.66M1.64M1.72M1.69M1.52M1.46M1.64M1.64M1.63M2.06M
Gains from Sales and DivestituresGains Divest
-0.01M-666.00-817.000.00M0.00M-0.01M0.00M
Other non-cash itemsOther Non-Cash
0.16M0.25M0.18M0.03M0.06M0.11M0.11M0.11M0.09M0.09M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.09M0.10M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.25M0.03M-0.10M-0.11M-0.06M-0.01M0.00M
Change in Account PayablesChange Payables
-0.45M0.25M-0.40M1.10M0.82M-0.43M-0.07M-0.78M0.17M0.12M0.39M-0.68M0.06M-0.69M1.19M-0.97M0.07M-0.09M1.92M-0.62M
Change in Accrued ExpensesChange Accrued Exp.
0.55M-2.24M0.51M2.11M0.09M-2.09M0.02M0.85M1.95M-2.76M1.35M0.84M0.38M-1.61M1.15M2.37M0.99M-4.78M1.03M3.40M
Change in Other Operating AssetsOther Assets Change
-0.71M-1.42M-0.62M2.23M0.45M-0.51M-0.17M0.82M0.33M-0.28M1.01M0.71M-1.16M-1.65M-0.88M-0.18M1.10M1.18M3.49M-2.96M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.02M0.01M-0.04M-0.04M-0.03M-0.09M-0.10M-0.05M0.10M-0.32M0.00M-0.10M0.10M-0.26M0.07M-0.21M0.12M-0.34M0.07M-0.22M
Other Working Capital ChangesOther WC Changes
0.69M1.43M0.58M-2.27M-0.49M0.42M0.08M-0.87M-0.23M-0.04M-1.01M-0.81M1.25M1.39M0.95M-0.03M-0.98M-1.52M-3.42M2.73M
Cash from OperationsCash from Ops.
-9.24M-12.28M-9.45M-10.62M-11.75M-14.42M-10.75M-12.03M-11.78M-15.49M-11.53M-13.47M-14.51M-14.08M-9.45M-11.98M-9.84M-18.43M-16.50M-16.79M
Investing Activities
Capital ExpendituresCapex
0.01M0.12M0.16M0.39M0.07M0.03M0.09M0.06M0.17M0.04M0.03M0.01M0.01M0.01M0.00M0.01M0.12M0.08M0.03M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.12M-0.16M-0.39M-0.07M-0.03M-0.09M-0.06M-0.17M-0.04M-0.03M-0.01M-0.01M-0.01M0.00M-0.01M-0.12M-0.08M-0.03M-0.02M
Purchase of InvestmentsInvestments Purchased
22.87M7.98M10.01M19.74M12.38M28.91M15.75M88.60M71.99M11.99M0.19M
Sale and Maturity of InvestmentsInvestments Sold
20.50M32.33M19.25M20.60M19.00M9.25M5.00M19.05M21.43M5.00M5.50M9.00M22.50M33.68M
Cash from Investing ActivitiesCash from Investing
-22.81M12.40M22.15M-0.88M8.15M18.97M9.16M-23.97M3.13M21.39M4.97M-5.42M5.49M-0.01M0.00M-0.01M-88.72M-63.07M10.48M33.47M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M0.19M0.03M0.04M0.04M0.24M28.38M-28.18M0.01M0.98M0.13M0.13M0.00M0.42M0.23M0.18M0.02M0.22M
Net Shares Issued and RepurchasedNet Shares Issued
0.01M0.19M0.03M0.04M0.04M0.24M28.38M-28.18M0.01M0.98M0.13M0.13M0.00M0.42M0.23M0.18M0.02M0.22M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.01M0.19M0.03M0.04M0.04M0.24M28.38M-28.18M0.01M0.98M0.13M0.13M0.00M0.42M0.23M0.18M0.02M0.22M
Other financing activities (as filed)
-0.05M-0.23M-0.04M-3.07M-0.59M
Cash from Financing ActivitiesCash from Financing
0.01M0.19M0.03M-0.02M-0.18M0.24M28.17M0.02M0.01M0.98M4.36M-0.04M13.81M-0.06M213.19M-0.36M0.18M0.02M0.22M
Additional items
Change in Cash
-32.04M0.32M12.73M-11.52M-3.78M4.79M26.59M-35.98M-8.63M6.88M-6.56M-14.52M-9.06M-0.28M-9.51M201.21M-98.92M-81.32M-6.00M16.90M
Ending Cash Balance
74.89M75.21M87.94M76.42M72.64M77.43M104.02M68.04M59.41M66.29M59.73M45.21M36.14M35.87M26.36M227.56M128.65M47.32M41.32M58.23M
Free Cash FlowFCF
-9.25M-12.40M-9.61M-11.02M-11.82M-14.45M-10.84M-12.08M-11.95M-15.53M-11.56M-13.48M-14.52M-14.09M-9.45M-11.98M-9.96M-18.51M-16.53M-16.80M
Net Cash FlowNCF
-32.04M0.32M12.73M-11.52M-3.78M4.79M26.59M-35.98M-8.63M6.88M-6.56M-14.52M-9.06M-0.28M-9.51M201.21M-98.92M-81.32M-6.00M16.90M

Immuneering Cash Flow Statement API

Pull Immuneering's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY